Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · IEX Real-Time Price · USD
4.110
+0.220 (5.66%)
At close: Mar 28, 2024, 4:00 PM
4.180
+0.070 (1.70%)
After-hours: Mar 28, 2024, 7:55 PM EDT

Vanda Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2004
Net Income
2.516.2833.1523.34115.5525.21-15.57-18.01-39.8720.19
Upgrade
Depreciation & Amortization
3.012.732.842.862.892.962.9811.8713.552.78
Upgrade
Share-Based Compensation
14.0416.2815.3713.3613.4611.6710.478.547.965.88
Upgrade
Other Operating Activities
-6.766.712.8512.21-85.96-9.840.14-10.530.8-110.4
Upgrade
Operating Cash Flow
12.831.9864.2151.7845.9529.99-1.98-8.112.45-81.55
Upgrade
Operating Cash Flow Growth
-59.98%-50.19%24.03%12.68%53.23%-----
Upgrade
Capital Expenditures
-0.38-0.68-0.55-1.8-1.02-25.37-1.66-1.41-2.53-0.77
Upgrade
Acquisitions
-100.67000000000
Upgrade
Change in Investments
88.9950.6-76.14-39.7-67.29-84.29-8.57-8.62-24.07-3.51
Upgrade
Other Investing Activities
----------7.76
Upgrade
Investing Cash Flow
-12.0649.93-76.7-41.5-68.31-109.66-10.23-10.03-26.6-12.04
Upgrade
Share Issuance / Repurchase
00.733.555.636.26107.135.257.754.3790.16
Upgrade
Other Financing Activities
---------0.28-0.44
Upgrade
Financing Cash Flow
00.733.555.636.26107.135.257.754.0989.73
Upgrade
Exchange Rate Effect
0.050.27-0.090.05-0-0.040.040.0100
Upgrade
Net Cash Flow
0.7982.91-9.0215.96-16.127.41-6.92-10.37-10.06-3.86
Upgrade
Free Cash Flow
12.4231.3163.6649.9844.934.62-3.65-9.519.92-82.32
Upgrade
Free Cash Flow Growth
-60.33%-50.83%27.37%11.24%872.89%-----
Upgrade
Free Cash Flow Margin
6.45%12.31%23.69%20.14%19.78%2.39%-2.21%-6.51%9.03%-164.13%
Upgrade
Free Cash Flow Per Share
0.220.551.150.920.850.09-0.08-0.220.23-2.37
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).